Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001193125-25-058964
Filing Date
2025-03-20
Accepted
2025-03-20 16:04:14
Documents
1
Effectiveness Date
2025-03-20

Document Format Files

Seq Description Document Type Size
1 25 d906084d25.htm 25 10473
  Complete submission text file 0001193125-25-058964.txt   11523
Mailing Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141
Business Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 (617) 949-4360
Omega Therapeutics, Inc. (Filer) CIK: 0001850838 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25 | Act: 34 | File No.: 001-40657 | Film No.: 25756419
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)